August 4, 2025

Repligen Corporation (RGEN) Investor Outlook: Exploring a 51% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with its potential upside of 51.14%. This life sciences..

Integer Holdings Corporation (ITGR) Stock Analysis: A 32% Potential Upside in the Healthcare Sector

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors seeking exposure to the dynamic world of medical..

Avidity Biosciences (RNA): Investor Outlook Reveals 85% Potential Upside Amid Biotech Innovations

Avidity Biosciences, Inc. (RNA), a pioneering biotechnology firm based in San Diego, California, stands as a beacon of innovation in the healthcare sector with its unique approach to RNA therapeutics...

Henry Schein, Inc. (HSIC) Investor Outlook: Navigating a Flat Market with a 11.57% Potential Upside

Henry Schein, Inc. (HSIC), a stalwart in the medical distribution industry, presents an intriguing case for investors looking to balance stability with growth potential. With a market capitalization of $8.5..

Revolution Medicines, Inc. (RVMD) Investor Outlook: Unpacking the 97% Potential Upside

Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage biotechnology company, is making waves in the healthcare sector with its focus on precision oncology. The company is headquartered in Redwood City, California,..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 15.65% Potential Upside with Promising Biotech Advances

For individual investors keeping an eye on the biotechnology sector, TG Therapeutics, Inc. (NASDAQ: TGTX) presents a compelling opportunity with its significant potential upside of 15.65%. As a leader in..

Rhythm Pharmaceuticals (RYTM) Investor Outlook: Analyzing a Potential 18% Upside in Biotech’s Growth Journey

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) has recently caught the attention of investors with its compelling market dynamics, positioned firmly within the biotechnology sector. Headquartered in Boston, Massachusetts, the company focuses..

McKesson Corporation (MCK): Investor Outlook on Healthcare Giant with 11.59% Potential Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, has long been a cornerstone in the medical distribution industry. With a significant market capitalization of $87.28 billion, McKesson operates..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A 71.91% Potential Upside Drives Investor Attention

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a prominent player in the biotechnology sector focusing on central nervous system (CNS) disorders, has been capturing investor interest with its significant growth potential and..

Koninklijke Philips N.V. (PHG): Analyst Ratings Suggest 23.83% Upside Potential for Healthcare Giant

Koninklijke Philips N.V. (PHG), the Dutch healthcare and medical devices corporation, presents an intriguing prospect for investors seeking exposure to the healthcare sector. With a market capitalization of $25.15 billion,..

Qiagen N.V. (QGEN) Stock Analysis: A Healthcare Leader with Steady Growth and Limited Upside

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector, is making waves in the Diagnostics & Research industry. With a robust market capitalization of $10.81 billion, Qiagen is..

ICON plc (ICLR) Stock Analysis: Evaluating a 29.86% Potential Upside for Investors

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors with its substantial potential upside. With a market..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 57.67% Potential Upside with Innovative Healthcare Solutions

Investors with a keen eye on the healthcare sector may find Globus Medical, Inc. (NYSE: GMED) a compelling consideration, particularly given its promising potential upside of 57.67%. This Audubon, Pennsylvania-based..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a 280.83% Upside Potential

Investors with a keen interest in the biotechnology sector may find Vaxcyte, Inc. (NASDAQ: PCVX) an intriguing prospect. With its current market capitalization standing at $4.26 billion, Vaxcyte is positioned..

ADMA Biologics Inc (ADMA)

⚠️ No article content returned.

..

Waters Corporation (WAT): Analyst Ratings Show Potential 28.82% Upside — What Investors Need to Know

Waters Corporation (NYSE: WAT), a leading player in the healthcare sector’s diagnostics and research industry, is drawing attention from investors with its strategic market positioning and promising growth prospects. Headquartered..

Novartis AG (NVS) Stock Analysis: Navigating Growth with a Strong Dividend Yield and Robust Revenue Expansion

Novartis AG (NVS), a heavyweight in the healthcare sector, stands as a formidable player in the global pharmaceutical market. Headquartered in Basel, Switzerland, the company is renowned for its innovative..

Solventum Corporation (SOLV) Investor Outlook: Examining a Promising 18.3% Potential Upside

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, offers a diverse portfolio of medical solutions that serve both consumer and professional markets. With a market capitalization of..

Humana Inc. (HUM) Stock Analysis: Potential 17% Upside Amid Healthcare Sector Dynamics

Humana Inc. (NYSE: HUM), a formidable player in the healthcare sector, offers a compelling case for investors seeking exposure to the healthcare plans industry. With a market capitalization of $29.74..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Growth in Healthcare with a 14.20% Revenue Surge

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Based in Cincinnati, Ohio, and operating across North America,..

Search

Funds

August 4, 2025

Search

Funds

August 4, 2025

FTSE 100

Funds